AIMEDBIO
IR
ENG
KOR
ABOUT US
Overview
Leadership
Corporate Governance
R&D
AimedBio’s Drug Development
P-ADC™
Pipeline
IR
Disclosure
Stock
Financial Information
PR
Notice
Press Release
Data Room
CAREERS
Our Culture
Recruitment Process
Job Opportunities
Disclosure
54 posts
NO.
Title
Date
Author
54
[Corrected description]Material Management Information related to Judgment of Investment(Application for IND Approval) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청)
2026-06-16
에임드바이오
53
Closure of Register of Shareholders or Designation of Record Date
2026-06-05
에임드바이오
52
Resolutions for Convocation of General Meeting of Shareholders (임시주주총회)
2026-06-05
에임드바이오
51
Material Management Information related to Judgment of Investment(Application for IND Approval)
2026-05-27
에임드바이오
50
[Corrected description]Quarterly Report (2026.03)
2026-05-15
에임드바이오
49
Quarterly Report (2026.03)
2026-05-15
에임드바이오
48
Material Management Information related to Judgment of Investment (ODS025 기술이전계약 관련 연구개발비 수령)
2026-05-06
에임드바이오
47
Report on the Grant of Stock Options
2026-03-27
에임드바이오
46
Outcomes of Annual Meeting of Shareholders
2026-03-27
에임드바이오
45
Forecast on Business Performance according to Consolidated Financial Statements(Fair Disclosure)
2026-03-26
에임드바이오
[Corrected description]Material Management Information related to Judgment of Investment(Application for IND Approval) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청)
에임드바이오
2026-06-16
Closure of Register of Shareholders or Designation of Record Date
에임드바이오
2026-06-05
Resolutions for Convocation of General Meeting of Shareholders (임시주주총회)
에임드바이오
2026-06-05
Material Management Information related to Judgment of Investment(Application for IND Approval)
에임드바이오
2026-05-27
[Corrected description]Quarterly Report (2026.03)
에임드바이오
2026-05-15
Quarterly Report (2026.03)
에임드바이오
2026-05-15
Material Management Information related to Judgment of Investment (ODS025 기술이전계약 관련 연구개발비 수령)
에임드바이오
2026-05-06
Report on the Grant of Stock Options
에임드바이오
2026-03-27
Outcomes of Annual Meeting of Shareholders
에임드바이오
2026-03-27
Forecast on Business Performance according to Consolidated Financial Statements(Fair Disclosure)
에임드바이오
2026-03-26
1
2
3
4
5